CoChat
Sign Up
Cited by 589

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention

Butler, Lisa M., Perone, Ylenia, Dehairs, Jonas, Lupien, Leslie E., de Laat, Vincent, Talebi, Ali, Loda, Massimo, Kinlaw, William B., Swinnen, Johannes V.·2020·Advanced Drug Delivery Reviews
DOI 10.1016/j.addr.2020.07.013PMC PMC7736102
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.addr.2020.07.013

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 47 references

Research works printed but not linked: 781

  1. Warburg, 1927, The metabolism of Tumors in the body, J. Gen. Physiol., 8, 519, 10.1085/jgp.8.6.519 · DOI · Paper page
  2. Swinnen, 2006, Increased lipogenesis in cancer cells: new players, novel targets, Curr. Opin. Clin. Nutr. Metab. Care, 9, 358
  3. Li, 2014, Mass spectrometry methodology in lipid analysis, Int. J. Mol. Sci., 15, 10492, 10.3390/ijms150610492 · DOI
  4. Lydic, 2018, Lipidomics unveils the complexity of the lipidome in metabolic diseases, Clin Transl Med, 7, 4, 10.1186/s40169-018-0182-9 · DOI
  5. van Meer, 2008, Membrane lipids: where they are and how they behave, Nat. Rev. Mol. Cell Biol., 9, 112, 10.1038/nrm2330 · DOI · Paper page
  6. Spector, 1966, Relationship between fatty acid and glucose utilization in Ehrlich ascites tumor cells, J. Lipid Res., 7, 657, 10.1016/S0022-2275(20)39247-6 · DOI
  7. Tator, 1966, Tracers for the detection of brain tumors. Evaluation of radioiodinated human serum albumin and radioiodinated fatty acid, Neurology, 16, 650, 10.1212/WNL.16.7.650 · DOI
  8. Mountford, 1982, Characterization of transformed cells and tumors by proton nuclear magnetic resonance spectroscopy, Cancer Res., 42, 2270
  9. Jensen, 1995, The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer, J. Pathol., 176, 343, 10.1002/path.1711760405 · DOI
  10. Ferro, 2017, 13, 285
  11. Hoy, 2017, Adipocyte-tumor cell metabolic crosstalk in breast Cancer, Trends Mol. Med., 23, 381, 10.1016/j.molmed.2017.02.009 · DOI
  12. Tworoger, 2016, Obesity and ovarian Cancer, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 208, 155
  13. Bi, 2019, Oncogene amplification in growth factor Signaling pathways renders cancers dependent on membrane lipid Remodeling, Cell Metab., 30, 525, 10.1016/j.cmet.2019.06.014 · DOI
  14. Rysman, 2010, De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation, Cancer Res., 70, 8117, 10.1158/0008-5472.CAN-09-3871 · DOI
  15. Talebi, 2018, Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy, Nat. Commun., 9, 2500, 10.1038/s41467-018-04664-0 · DOI · Paper page
  16. Bensaad, 2014, Fatty acid uptake and lipid storage induced by HIF-1alpha contribute to cell growth and survival after hypoxia-reoxygenation, Cell Rep., 9, 349, 10.1016/j.celrep.2014.08.056 · DOI
  17. Bailey, 2015, Antioxidant role for lipid droplets in a stem cell niche of Drosophila, Cell, 163, 340, 10.1016/j.cell.2015.09.020 · DOI
  18. Lazar, 2018, A new role for extracellular vesicles: how small vesicles can feed tumors' big appetite, J. Lipid Res., 59, 1793, 10.1194/jlr.R083725 · DOI
  19. Rolin, 2011, Effects of lysophospholipids on tumor microenvironment, Cancer Microenviron., 4, 393, 10.1007/s12307-011-0088-1 · DOI
  20. Balog, 2013, Intraoperative tissue identification using rapid evaporative ionization mass spectrometry, Sci. Transl. Med., 5, 10.1126/scitranslmed.3005623 · DOI
  21. Shan, 2012, Measurement of phospholipids may improve diagnostic accuracy in ovarian cancer, PLoS One, 7, 10.1371/journal.pone.0046846 · DOI
  22. Wang, 2012, Metabonomics approach to assessing the modulatory effects of St John's wort, ginsenosides, and clomipramine in experimental depression, J. Proteome Res., 11, 6223, 10.1021/pr300891v · DOI
  23. Guo, 2012, Probing gender-specific lipid metabolites and diagnostic biomarkers for lung cancer using Fourier transform ion cyclotron resonance mass spectrometry, Clin. Chim. Acta, 414, 135, 10.1016/j.cca.2012.08.010 · DOI
  24. Yu, 2017, Global lipidomics identified plasma lipids as novel biomarkers for early detection of lung cancer, Oncotarget, 8, 107899, 10.18632/oncotarget.22391 · DOI
  25. Patel, 2014, A novel three serum phospholipid panel differentiates normal individuals from those with prostate cancer, PLoS One, 9, 10.1371/journal.pone.0088841 · DOI
  26. Hao, 2019, Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data, BMC bioinformatics, 20, 195, 10.1186/s12859-019-2734-4 · DOI
  27. Grant, 2011, High throughput automated LC-MS/MS analysis of endogenous small molecule biomarkers, Clin. Lab. Med., 31, 429, 10.1016/j.cll.2011.07.008 · DOI
  28. Dehairs, 2015, Lipidomics in drug development, Drug Discov. Today Technol., 13, 33, 10.1016/j.ddtec.2015.03.002 · DOI
  29. Wolrab, 2020, Validation of lipidomic analysis of human plasma and serum by supercritical fluid chromatography-mass spectrometry and hydrophilic interaction liquid chromatography-mass spectrometry, Anal. Bioanal. Chem., 412, 2375, 10.1007/s00216-020-02473-3 · DOI
  30. O'Donnell, 2019, LIPID MAPS: Serving the next generation of lipid researchers with tools, resources, data, and training, Sci. Signal., 12
  31. Fahy, 2009, Update of the LIPID MAPS comprehensive classification system for lipids, J. Lipid Res., 50, S9, 10.1194/jlr.R800095-JLR200 · DOI · Paper page
  32. Stephenson, 2017, Lipidomics in translational research and the clinical significance of lipid-based biomarkers, Transl. Res., 189, 13, 10.1016/j.trsl.2017.06.006 · DOI
  33. Hsu, 2018, Mass spectrometry-based shotgun lipidomics - a critical review from the technical point of view, Anal. Bioanal. Chem., 410, 6387, 10.1007/s00216-018-1252-y · DOI
  34. O'Donnell, 2020, Lipidomics: current state of the art in a fast moving field, Wiley Interdiscip. Rev. Syst. Biol. Med., 12, 10.1002/wsbm.1466 · DOI
  35. Zhu, 2019, Boronic derivatization of Monoacylglycerol and monitoring in biofluids, Anal. Chem., 91, 6724, 10.1021/acs.analchem.9b00805 · DOI
  36. Guo, 2016, Stable isotope labeling - liquid chromatography/mass spectrometry for quantitative analysis of androgenic and progestagenic steroids, Anal. Chim. Acta, 905, 106, 10.1016/j.aca.2015.12.010 · DOI
  37. Griffiths, 2016, New methods for analysis of oxysterols and related compounds by LC-MS, J. Steroid Biochem. Mol. Biol., 162, 4, 10.1016/j.jsbmb.2015.11.017 · DOI
  38. von Gerichten, 2017, Diastereomer-specific quantification of bioactive hexosylceramides from bacteria and mammals, J. Lipid Res., 58, 1247, 10.1194/jlr.D076190 · DOI
  39. Thomas, 2008, Ozone-induced dissociation: elucidation of double bond position within mass-selected lipid ions, Anal. Chem., 80, 303, 10.1021/ac7017684 · DOI
  40. Groessl, 2015, High resolution ion mobility-mass spectrometry for separation and identification of isomeric lipids, Analyst, 140, 6904, 10.1039/C5AN00838G · DOI
  41. Zhang, 2019, Online photochemical derivatization enables comprehensive mass spectrometric analysis of unsaturated phospholipid isomers, Nat. Commun., 10, 79, 10.1038/s41467-018-07963-8 · DOI
  42. Thiele, 2019, Multiplexed and single cell tracing of lipid metabolism, Nat. Methods, 16, 1123, 10.1038/s41592-019-0593-6 · DOI
  43. Marien, 2015, Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles, Int. J. Cancer, 137, 1539, 10.1002/ijc.29517 · DOI
  44. O'Donnell, 2018, Phospholipid signaling in innate immune cells, J. Clin. Invest., 128, 2670, 10.1172/JCI97944 · DOI
  45. Goto-Inoue, 2011, Imaging mass spectrometry for lipidomics, Biochim. Biophys. Acta, 1811, 961, 10.1016/j.bbalip.2011.03.004 · DOI
  46. Fernandez, 2011, Matrix-assisted laser desorption ionization imaging mass spectrometry in lipidomics, Anal. Bioanal. Chem., 401, 29, 10.1007/s00216-011-4696-x · DOI
  47. Amstalden van Hove, 2010, A concise review of mass spectrometry imaging, J. Chromatogr. A, 1217, 3946, 10.1016/j.chroma.2010.01.033 · DOI
  48. Rohner, 2005, MALDI mass spectrometric imaging of biological tissue sections, Mech. Ageing Dev., 126, 177, 10.1016/j.mad.2004.09.032 · DOI
  49. Song, 2019, Virtual calibration quantitative mass spectrometry imaging for accurately mapping Analytes across Heterogenous biotissue, Anal. Chem., 91, 2838, 10.1021/acs.analchem.8b04762 · DOI
  50. Trim, 2016, Small molecule MALDI MS imaging: current technologies and future challenges, Methods, 104, 127, 10.1016/j.ymeth.2016.01.011 · DOI
  51. Sparvero, 2012, Mapping of phospholipids by MALDI imaging (MALDI-MSI): realities and expectations, Chem. Phys. Lipids, 165, 545, 10.1016/j.chemphyslip.2012.06.001 · DOI
  52. Enomoto, 2011, Visualization of phosphatidylcholine, lysophosphatidylcholine and sphingomyelin in mouse tongue body by matrix-assisted laser desorption/ionization imaging mass spectrometry, Anal. Bioanal. Chem., 400, 1913, 10.1007/s00216-011-4924-4 · DOI
  53. Ishikawa, 2012, Increased expression of phosphatidylcholine (16:0/18:1) and (16:0/18:2) in thyroid papillary cancer, PLoS One, 7, 10.1371/journal.pone.0048873 · DOI
  54. Schwamborn, 2010, Molecular imaging by mass spectrometry--looking beyond classical histology, Nat. Rev. Cancer, 10, 639, 10.1038/nrc2917 · DOI
  55. Pirman, 2013, Changes in Cancer cell metabolism revealed by direct sample analysis with MALDI mass spectrometry, PLoS One, 8, 10.1371/journal.pone.0061379 · DOI
  56. Drake, 2017, MALDI mass spectrometry imaging of N-linked Glycans in Cancer tissues, Adv. Cancer Res., 134, 85, 10.1016/bs.acr.2016.11.009 · DOI
  57. Pirman, 2013, Changes in cancer cell metabolism revealed by direct sample analysis with MALDI mass spectrometry, PLoS One, 8, 10.1371/journal.pone.0061379 · DOI
  58. Lagarrigue, 2012, Matrix-assisted laser desorption/ionization imaging mass spectrometry: a promising technique for reproductive research, Biol. Reprod., 86, 74, 10.1095/biolreprod.111.094896 · DOI
  59. Hegele, 2016, Multidimensional regulation of lipoprotein lipase: impact on biochemical and cardiovascular phenotypes, J. Lipid Res., 57, 1601, 10.1194/jlr.C070946 · DOI · Paper page
  60. Mead, 2002, Lipoprotein lipase: structure, function, regulation, and role in disease, J Mol Med (Berl), 80, 753, 10.1007/s00109-002-0384-9 · DOI
  61. Fielding, 1991, Chapter 15 Dynamics of lipoprotein transport in the circulatory system, 427, 10.1016/S0167-7306(08)60343-9 · DOI
  62. DeBerardinis, 2007, Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis, PNAS, 104, 19345, 10.1073/pnas.0709747104 · DOI · Paper page
  63. Enoch, 1976, Mechanism of rat liver microsomal stearyl-CoA desaturase. Studies of the substrate specificity, enzyme-substrate interactions, and the function of lipid, J. Biol. Chem., 251, 5095, 10.1016/S0021-9258(17)33223-4 · DOI
  64. Bai, 2015, X-ray structure of a mammalian stearoyl-CoA desaturase, Nature, 524, 252, 10.1038/nature14549 · DOI
  65. Baenke, 2013, Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development, Dis. Model. Mech., 6, 1353, 10.1242/dmm.011338 · DOI · Paper page
  66. Aja, 2006, Intracerebroventricular C75 decreases meal frequency and reduces AgRP gene expression in rats, Am. J. Physiol. Regul. Integr. Comp. Physiol., 291, R148, 10.1152/ajpregu.00041.2006 · DOI
  67. Menendez, 2007, Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis, Nat. Rev. Cancer, 7, 763, 10.1038/nrc2222 · DOI · Paper page
  68. Chirala, 2003, Fatty acid synthesis is essential in embryonic development: fatty acid synthase null mutants and most heterozygotes die in utero, PNAS, 100, 6358, 10.1073/pnas.0931394100 · DOI
  69. Bhatt, 2012, Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma, Proc. Natl. Acad. Sci., 109, 11818, 10.1073/pnas.1205995109 · DOI
  70. Cai, 2015, Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer, Med. Oncol., 32, 391, 10.1007/s12032-014-0391-z · DOI
  71. Di Vizio, 2008, Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase, Cell cycle (Georgetown, Tex.), 7, 2257, 10.4161/cc.7.14.6475 · DOI
  72. Gelebart, 2012, Blockade of fatty acid synthase triggers significant apoptosis in mantle cell lymphoma, PLoS One, 7, 10.1371/journal.pone.0033738 · DOI
  73. Ookhtens, 1984, Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor, Am. J. Phys., 247, R146
  74. Turrado, 2012, New synthetic inhibitors of fatty acid synthase with anticancer activity, J. Med. Chem., 55, 5013, 10.1021/jm2016045 · DOI
  75. Zadra, 2018, Metabolic vulnerabilities of prostate Cancer: diagnostic and therapeutic opportunities, Cold Spring Harb Perspect Med, 8, a030569, 10.1101/cshperspect.a030569 · DOI
  76. Migita, 2009, Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer, J. Natl. Cancer Inst., 101, 519, 10.1093/jnci/djp030 · DOI
  77. Swinnen, 2000, Selective activation of the fatty acid synthesis pathway in human prostate cancer, Int. J. Cancer, 88, 176, 10.1002/1097-0215(20001015)88:2<176::AID-IJC5>3.0.CO;2-3 · DOI
  78. Baron, 2004, Fatty acid synthase: a metabolic oncogene in prostate cancer?, J. Cell. Biochem., 91, 47, 10.1002/jcb.10708 · DOI
  79. Gansler, 1997, Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival, Hum. Pathol., 28, 686, 10.1016/S0046-8177(97)90177-5 · DOI
  80. Visca, 2004, Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma, Anticancer Res., 24, 4169
  81. Sebastiani, 2004, Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma, Gynecol. Oncol., 92, 101, 10.1016/j.ygyno.2003.10.027 · DOI
  82. Ogino, 2007, Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype, Hum. Pathol., 38, 842, 10.1016/j.humpath.2006.11.018 · DOI
  83. Ogino, 2008, Cohort study of fatty acid synthase expression and patient survival in Colon Cancer, J. Clin. Oncol., 26, 5713, 10.1200/JCO.2008.18.2675 · DOI
  84. Agostini, 2004, Fatty acid synthase is required for the proliferation of human oral squamous carcinoma cells, Oral Oncol., 40, 728, 10.1016/j.oraloncology.2004.01.011 · DOI
  85. Suburu, 2012, Lipids and prostate cancer, Prostaglandins & Other Lipid Mediators, 98, 1, 10.1016/j.prostaglandins.2012.03.003 · DOI
  86. Swinnen, 2002, Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer, International Journal of Cancer. Journal International Du Cancer, 98, 19, 10.1002/ijc.10127 · DOI
  87. Pflug, 2003, Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model, Prostate, 57, 245, 10.1002/pros.10297 · DOI
  88. Epstein, 1995, OA-519 (fatty acid synthase) as an independent predictor of pathologic stage in adenocarcinoma of the prostate, Urology, 45, 81, 10.1016/S0090-4295(95)96904-7 · DOI
  89. Van de Sande, 2002, Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells, Cancer Res., 62, 642
  90. Rossi, 2003, Fatty acid synthase expression defines distinct molecular signatures in prostate Cancer1 1 NCI (Director's challenge CA84995-04, SPORE in prostate Cancer CA90381-01A1, and PO1 CA89021-02), Novartis investigator, and CaPCURE awards, Mol. Cancer Res., 1, 707
  91. Shah, 2006, Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma☆, Hum. Pathol., 37, 401, 10.1016/j.humpath.2005.11.022 · DOI
  92. Scott, 2012, Metabolic regulation of Invadopodia and invasion by acetyl-CoA carboxylase 1 and De novo lipogenesis, PLoS One, 7, 10.1371/journal.pone.0029761 · DOI
  93. Yoshii, 2013, Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome, PLoS One, 8, 10.1371/journal.pone.0064570 · DOI
  94. De Schrijver, 2003, RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells, Cancer Res., 63, 3799
  95. Zaidi, 2012, ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms, Mol. Cancer Ther., 11, 1925, 10.1158/1535-7163.MCT-12-0095 · DOI
  96. Beckers, 2007, Chemical inhibition of acteyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells, Cancer Res., 67, 8180, 10.1158/0008-5472.CAN-07-0389 · DOI
  97. Brusselmans, 2005, RNA interference-mediated silencing of the acetyl-CoA-carboxylase-a gene induces growth inhibition and apoptosis of prostate cancer cells, Cancer Res., 65, 6719, 10.1158/0008-5472.CAN-05-0571 · DOI · Paper page
  98. Bruning, 2018, Impairment of Angiogenesis by Fatty Acid Synthase Inhibition Involves mTOR Malonylation, Cell Metab., 28, 10.1016/j.cmet.2018.07.019 · DOI
  99. Zadra, 2014, A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis, EMBO molecular medicine, 6, 519, 10.1002/emmm.201302734 · DOI
  100. Dale, 2006, Statins and cancer risk: a meta-analysis, Jama, 295, 74, 10.1001/jama.295.1.74 · DOI
  101. Ahern, 2011, Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study, J. Natl. Cancer Inst., 103, 1461, 10.1093/jnci/djr291 · DOI · Paper page
  102. Allott, 2020, Statin use is associated with lower risk of PTEN-null and lethal prostate Cancer, Clin. Cancer Res., 26, 1086, 10.1158/1078-0432.CCR-19-2853 · DOI
  103. Nielsen, 2012, Statin use and reduced cancer-related mortality, N. Engl. J. Med., 367, 1792, 10.1056/NEJMoa1201735 · DOI · Paper page
  104. Gaglio, 2011, Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth, Mol. Syst. Biol., 7, 523, 10.1038/msb.2011.56 · DOI · Paper page
  105. Beloribi-Djefaflia, 2016, Lipid metabolic reprogramming in cancer cells, Oncogenesis, 5, 10.1038/oncsis.2015.49 · DOI
  106. Amemori, 2007, Adipocytes and preadipocytes promote the proliferation of colon cancer cells in vitro, Am. J. Physiol. Gastrointest. Liver Physiol., 292, G923, 10.1152/ajpgi.00145.2006 · DOI
  107. Anastasiou, 2012, Breathless cancer cells get fat on glutamine, Cell Res., 22, 443, 10.1038/cr.2012.5 · DOI
  108. Dirat, 2011, Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion, Cancer Res., 71, 2455, 10.1158/0008-5472.CAN-10-3323 · DOI · Paper page
  109. Cao, 2018, Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma, Int. J. Oncol., 53, 137
  110. Altman, 2016, From Krebs to clinic: glutamine metabolism to cancer therapy, Nat. Rev. Cancer, 16, 619, 10.1038/nrc.2016.71 · DOI · Paper page
  111. Yoshii, 2009, Cytosolic acetyl-CoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetyl-CoA/acetate metabolism, Cancer Sci., 100, 821, 10.1111/j.1349-7006.2009.01099.x · DOI
  112. Yoshii, 2015, Acetate/acetyl-CoA metabolism associated with cancer fatty acid synthesis: overview and application, Cancer Lett., 356, 211, 10.1016/j.canlet.2014.02.019 · DOI
  113. Chen, 2020, GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK/mTORC1 signaling, JCI Insight, 5, 10.1172/jci.insight.131596 · DOI
  114. Hamann, 2018, Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer—effects of hypoxia, FASEB J., 32, 10.1096/fj.201800360R · DOI
  115. Spector, 1967, The importance of free fatty acid in tumor nutrition, Cancer Res., 27, 1580
  116. Louie, 2013, Cancer cells incorporate and remodel exogenous palnmitate into structural and oncogenic signaling lipids, Biochim. Biophys. Acta, 1831, 566
  117. Klein, 2001, Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells, J. Exp. Med., 194, 1625, 10.1084/jem.194.11.1625 · DOI
  118. Rombout, 2015, Lipoprotein lipase SNPs rs13702 and rs301 correlate with clinical outcome in chronic lymphocytic leukemia patients, PLoS One, 10, 10.1371/journal.pone.0121526 · DOI
  119. Heintel, 2005, High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia, Leuk. Lymphoma, 19, 1216
  120. Baba, 2006, Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast cancer subtype, Breast Cancer Res. Treat., 98, 91, 10.1007/s10549-005-9135-2 · DOI
  121. Van Bockstaele, 2007, Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia, Clin. Chem., 53, 204, 10.1373/clinchem.2006.076331 · DOI
  122. Kristensen, 2016, LPL gene expression is associated with poor prognosis in CLL and closely related to NOTCH1 mutations, Eur. J. Haematol., 97, 175, 10.1111/ejh.12700 · DOI
  123. Matrai, 2017, Lipoprotein lipase as a prognostic marker in chronic lymphocytic Leukemia, Pathology oncology research : POR, 23, 165, 10.1007/s12253-016-0132-z · DOI
  124. Cao, 2017, Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells, Liver Int., 37, 80, 10.1111/liv.13183 · DOI
  125. Camarda, 2016, Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer, Nat. Med., 22, 427, 10.1038/nm.4055 · DOI
  126. Monaco, 2017, Fatty acid metabolism in breast cancer subtypes, Oncotarget, 8, 29487, 10.18632/oncotarget.15494 · DOI
  127. Castellano-Castillo, 2018, Adipose tissue LPL methylation is associated with triglyceride concentrations in the metabolic syndrome, Clin. Chem., 64, 210, 10.1373/clinchem.2017.277921 · DOI
  128. Prat, 2010, Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer, Breast Cancer Research : BCR, 12, R68, 10.1186/bcr2635 · DOI
  129. Dong, 2017, Diet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling, Oncotarget, 8, 22550, 10.18632/oncotarget.15123 · DOI
  130. Prieto, 2018, LPL protein in chronic lymphocytic leukaemia have different origins in mutated and Unmutated patients. Advances for a new prognostic marker in CLL, Br. J. Haematol., 182, 521, 10.1111/bjh.15427 · DOI
  131. Menard, 2016, Metastasis stimulation by hypoxia and aciodosis-induced extracellular lipid uptake is mediated by proteoglycan-dependent endocytosis, Cancer Res., 76, 4828, 10.1158/0008-5472.CAN-15-2831 · DOI
  132. Davies, 2010, GPIHP1 is responsible for the entry of lipoprotein lipase into capillaries, Cell Metab., 12, 42, 10.1016/j.cmet.2010.04.016 · DOI · Paper page
  133. Balaban, 2019, Extracellular fatty acids are the Major contributor to lipid synthesis in prostate Cancer, Mol. Cancer Res., 17, 949, 10.1158/1541-7786.MCR-18-0347 · DOI · Paper page
  134. Dong, 2013, The endothelial lipase protein is promising urinary biomarker for diagnosis of gastric cancer, Diagn. Pathol., 8, 45, 10.1186/1746-1596-8-45 · DOI
  135. Slebe, 2016, FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth, Nat. Commun., 7, 11199, 10.1038/ncomms11199 · DOI
  136. Akutagawa, 2018, Cancer-adipose tissue interaction and fluid flow synergistically modulate cell kinetics, HER2 expression, and trastuzumab efficacy in gastric cancer, Gastric Cancer, 21, 946, 10.1007/s10120-018-0829-7 · DOI
  137. Wang, 2018, JAK/STAT3-regulated fatty acid beta-oxidation is critical for breast Cancer stem cell self-renewal and Chemoresistance, Cell Metab., 27, 136, 10.1016/j.cmet.2017.11.001 · DOI
  138. Pagano, 2017, Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis, Pharmacol. Res., 119, 227, 10.1016/j.phrs.2017.02.002 · DOI
  139. Chen, 2014, XBP1 promotes triple-negative breast cancer by controlling the HIF1alpha pathway, Nature, 508, 103, 10.1038/nature13119 · DOI
  140. Zhu, 2016, Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-kappaB-mediated epithelial-mesenchymal transition, J. Hematol. Oncol., 9, 127, 10.1186/s13045-016-0361-3 · DOI
  141. Pan, 2019, CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3beta/beta-catenin pathway, J. Exp. Clin. Cancer Res., 38, 52, 10.1186/s13046-019-1049-7 · DOI
  142. Zhao, 2017, Exogenous lipids promote the growth of breast cancer cells via CD36, Oncol. Rep., 38, 2105, 10.3892/or.2017.5864 · DOI
  143. Pascual, 2017, Targeting metastasis-initiating cells through the fatty acid receptor CD36, Nature, 541, 41, 10.1038/nature20791 · DOI
  144. Feng, 2019, CD36-mediated metabolic rewiring of breast cancer cells promotes resistance to HER2-targeted therapies, Cell Rep., 29, 3405, 10.1016/j.celrep.2019.11.008 · DOI
  145. Watt, 2019, Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer, Sci. Transl. Med., 11, 10.1126/scitranslmed.aau5758 · DOI
  146. Nath, 2015, Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma, Sci. Rep., 5, 14752, 10.1038/srep14752 · DOI
  147. Aloia, 2019, A fatty acid oxidation-dependent metabolic shift regulates the adaptation of BRAF-mutated melanoma to MAPK inhibitors, Clin. Cancer Res., 10.1158/1078-0432.CCR-19-0253 · DOI · Paper page
  148. Bensaad, 2014, Fatty acid uptake and lipid storage induced by HIF-1alpha contribute to cell growth and survival after hypoxia-reoxygenation, Cell Rep., 9, 349, 10.1016/j.celrep.2014.08.056 · DOI
  149. Antalis, 2010, High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation, Breast Cancer Res. Treat., 122, 661, 10.1007/s10549-009-0594-8 · DOI
  150. Chamras, 2002, Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation, J. Nutr. Biochem., 13, 711, 10.1016/S0955-2863(02)00230-9 · DOI
  151. Przybytkowski, 2007, Upregulation of cellular triacylglycerol - free fatty acid cycling by oleate is associated with long-term serum-free survival of human breast cancer cells, Biochemistry and cell biology = Biochimie et biologie cellulaire, 85, 301, 10.1139/O07-001 · DOI
  152. Shiu, 1984, Alteration of cell shape, adhesion, and lipid accumulation in human breast cancer cells (T-47D) by human prolactin and growth hormone, Cancer Res., 44, 1178
  153. Nassar, 2018, Peri-prostatic adipose tissue: the metabolic microenvironment of prostate cancer, BJU Int., 121, 9, 10.1111/bju.14173 · DOI
  154. Balaban, 2017, Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration, Cancer and Metab., 5, 1, 10.1186/s40170-016-0163-7 · DOI
  155. Go, 2012, Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis, Yale J. Biol. Med., 85, 19
  156. Blücher, 2017, Obesity and breast Cancer: current insights on the role of fatty acids and lipid metabolism in promoting breast Cancer growth and progression, Front. Endocrinol., 8, 293, 10.3389/fendo.2017.00293 · DOI
  157. Nieman, 2013, Adipose tissue and adipocytes support tumorigenesis and metastasis, Biochim. Biophys. Acta, 1831, 1533, 10.1016/j.bbalip.2013.02.010 · DOI
  158. Nieman, 2011, Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth, Nat. Med., 17, 1498, 10.1038/nm.2492 · DOI · Paper page
  159. Guaita-Esteruelas, 2017, Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins, Mol. Carcinog., 56, 208, 10.1002/mc.22485 · DOI
  160. Chiu, 2016, Cardiomyocyte VEGF regulates endothelial cell GPIHBP1 to relocate lipoprotein lipase to the coronary lumen during diabetes mellitus, Arterioscler. Thromb. Vasc. Biol., 36, 145, 10.1161/ATVBAHA.115.306774 · DOI
  161. Park, 2017, Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse model, Am. J. Cancer Res., 7, 727
  162. Heemers, 2001, Androgens stimulate lipogenic gene expression by activation of sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding pathway, Mol. Endocrinol., 15, 1817, 10.1210/mend.15.10.0703 · DOI
  163. Andersen, 2016, Risk factor SORL1: from genetic association to functional validation in Alzheimer's disease, Acta Neuropathol., 132, 653, 10.1007/s00401-016-1615-4 · DOI · Paper page
  164. Lupien, 2019, Endocytosis of very low-density lipoproteins: an unexpected mechanism for lipid acquisition by breast cancer cells, J. Lipid Res., 61, 1
  165. Olsen, 2010, Fatty acid synthesis is a therapeutic target in Human Liposarcoma, Int. J. Oncol., 36, 1309
  166. V. Daniels, K. Smans, I. Royaux, M. Chypre, J. Swinnen, N. Zaidi, Cancer cells differentially activate and thrive on de novo lipid synthesis pathways in a low-lipid environment., PloS one, 9(9):e106913, 2014 (2014). · DOI
  167. Zaidi, 2013, Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids, Prog. Lipid Res., 52, 585, 10.1016/j.plipres.2013.08.005 · DOI
  168. Menard, 2017, Functional role of extracellular vesicles and lipoproteins in the tumour microenvironment, Philos. Trans. R. Soc. B, 373
  169. Herroon, 2013, Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms, Oncotarget, 4, 2108, 10.18632/oncotarget.1482 · DOI
  170. Mentoor, 2019, Fatty acids: adiposity and breast cancer chemotherapy, a bad synergy?, Prostaglandins Leukot. Essent. Fat. Acids, 140, 18, 10.1016/j.plefa.2018.11.009 · DOI
  171. Ecker, 2010, Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes, Proc. Natl. Acad. Sci. U. S. A., 107, 7817, 10.1073/pnas.0912059107 · DOI
  172. Yang, 2017, Aspirin suppresses the abnormal lipid metabolism in liver cancer cells via disrupting an NFkappaB-ACSL1 signaling, Biochem. Biophys. Res. Commun., 486, 827, 10.1016/j.bbrc.2017.03.139 · DOI
  173. Vargas, 2016, 3'UTR polymorphism in ACSL1 gene correlates with expression levels and poor clinical outcome in Colon Cancer patients, PLoS One, 11, 10.1371/journal.pone.0168423 · DOI
  174. Krammer, 2011, Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells, Int. J. Med. Sci., 8, 599, 10.7150/ijms.8.599 · DOI
  175. Tang, 2018, Fatty acid activation in carcinogenesis and cancer development: essential roles of long-chain acyl-CoA synthetases, Oncol. Lett., 16, 1390
  176. Amiri, 2018, Diverse roles of fatty acid binding proteins (FABPs) in development and pathogenesis of cancers, Gene, 676, 171, 10.1016/j.gene.2018.07.035 · DOI
  177. Hancke, 2010, Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients, Breast Cancer Res. Treat., 119, 367, 10.1007/s10549-009-0577-9 · DOI
  178. Lass, 2011, Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores, Prog. Lipid Res., 50, 14, 10.1016/j.plipres.2010.10.004 · DOI
  179. Ohata, 2017, Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition, Cancer Med., 6, 1049, 10.1002/cam4.1020 · DOI
  180. Das, 2001, Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues, Clin. Cancer Res., 7, 1706
  181. de Wit, 2005, Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays, Br. J. Cancer, 92, 2249, 10.1038/sj.bjc.6602612 · DOI
  182. Al Fayi, 2016, The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance, Oncotarget, 7, 82783, 10.18632/oncotarget.12635 · DOI
  183. Wang, 2016, Dysregulated fatty acid metabolism in hepatocellular carcinoma, Hepatic Oncol., 3, 241, 10.2217/hep-2016-0012 · DOI
  184. Holder, 2013, High steroyl-CoA desaturase 1 expression is associated with shgorter survival in breast cancer patients, Breast Cancer Res. Treat., 137, 319, 10.1007/s10549-012-2354-4 · DOI
  185. Presler, 2018, Increased expression of the gene encoding stearoyl-CoA desaturase 1 in human bladder cancer, Mol. Cell. Biochem., 447, 217, 10.1007/s11010-018-3306-z · DOI
  186. Guo, 2014, Targeting SREBP-1-driven lipid metabolism to treat cancer, Curr. Pharm. Des., 20, 2619, 10.2174/13816128113199990486 · DOI
  187. Notarnicola, 2018, Differential tissue fatty acids profiling between colorectal cancer patients with and without synchronous metastasis, Int. J. Mol. Sci., 19, 10.3390/ijms19040962 · DOI
  188. Mika, 2020, Preferential uptake of polyunsaturated fatty acids by colorectal cancer cells, Sci. Rep., 10, 1954, 10.1038/s41598-020-58895-7 · DOI
  189. Tesfay, 2019, Stearoyl-CoA desaturase 1 protects ovarian Cancer cells from Ferroptotic cell death, Cancer Res., 79, 5355, 10.1158/0008-5472.CAN-19-0369 · DOI
  190. Piao, 2019, Inhibition of stearoyl CoA desaturase-1 activity suppresses tumour progression and improves prognosis in human bladder cancer, J. Cell. Mol. Med., 23, 2064, 10.1111/jcmm.14114 · DOI
  191. Pisanu, 2018, Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma, J. Exp. Clin. Cancer Res., 37, 318, 10.1186/s13046-018-0989-7 · DOI
  192. Imamura, 2017, Discovery of novel and potent Stearoyl coenzyme a desaturase 1 (SCD1) inhibitors as anticancer agents, Bioorg. Med. Chem., 25, 3768, 10.1016/j.bmc.2017.05.016 · DOI
  193. Peck, 2016, Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments, Cancer Metab, 4, 6, 10.1186/s40170-016-0146-8 · DOI
  194. Lewis, 2015, SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme, Oncogene, 34, 5128, 10.1038/onc.2014.439 · DOI
  195. Ackerman, 2018, Triglycerides promote lipid homeostasis during hypoxic stress by balancing fatty acid saturation, Cell Rep., 24, 2596, 10.1016/j.celrep.2018.08.015 · DOI
  196. Muir, 2013, Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma, Cancer Res., 73, 4722, 10.1158/0008-5472.CAN-12-3797 · DOI
  197. Pender-Cudlip, 2013, Delta-6-desaturase activity and arachidonic acid synthesis are increased in human breast cancer tissue, Cancer Sci., 104, 760, 10.1111/cas.12129 · DOI
  198. K. Vriens, S. Christen, S. Parik, D. Broekaert, K. Yoshinaga, A. Talebi, J. Dehairs, C. Escalona-Noguero, R. Schmieder, T. Cornfield, C. Charlton, L. Romero-Perez, M. Rossi, G. Rinaldi, M.F. Orth, R. Boon, A. Kerstens, S.Y. Kwan, B. Faubert, A. Mendez-Lucas, C.C. Kopitz, T. Chen, J. Fernandez-Garcia, J.A.G. Duarte, A.A. Schmitz, P. Steigemann, M. Najimi, A. Hagebarth, J.A. Van Ginderachter, E. Sokal, N. Gotoh, K.K. Wong, C. Verfaillie, R. Derua, S. Munck, M. Yuneva, L. Beretta, R.J. DeBerardinis, J.V. Swinnen, L. Hodson, D. Cassiman, C. Verslype, S. Christian, S. Grunewald, T.G.P. Grunewald, S.M. Fendt, Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity, Nature, 566 (2019) 403–406. · DOI
  199. Hansen-Petrik, 2002, Selective inhibition of Delta-6 desaturase impedes intestinal tumorigenesis, Cancer Lett., 175, 157, 10.1016/S0304-3835(01)00715-7 · DOI
  200. Magtanong, 2019, Exogenous monounsaturated fatty acids promote a Ferroptosis-resistant cell state, Cell Chem Biol, 26, 420, 10.1016/j.chembiol.2018.11.016 · DOI

200 of 781 shown

Cited by

Sorted by citations

Metadata

Authors
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V.
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2020
Volume
159
Pages
245-293
ISSN
0169-409X
DOI
10.1016/j.addr.2020.07.013
PMC
PMC7736102
Cited by
589
References
47
Language
en
Licence
Funders
  • KU Leuven (C16/15/073, C32/17/052)
  • Interreg
  • Fonds Wetenschappelijk Onderzoek
  • U.S. Department of Defense (P50CA211024)
  • Stichting Tegen Kanker
  • Movember Foundation (MRTA3)
  • Kom op tegen Kanker
  • Norris Cotton Cancer Center
  • Prostate Cancer Foundation
  • National Institutes of Health (RO1CA58961, PC160357, PC180582, P50CA211024, R01CA187918, RO1CA131945)
  • Dartmouth College (P30CA023108)
  • Prostate Cancer Foundation of Australia (2711)
  • Cancer Council South Australia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review